According to Swedish Orphan Biovitrum's latest financial reports the company's current earnings are A$2.45 Billion. , an increase over its 2023 earnings that were of A$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | A$0.84 B | 36.04% |
2023 | A$0.61 B | 6.31% |
2022 | A$0.58 B | -9.56% |
2021 | A$0.64 B | -21.42% |
2020 | A$0.81 B | 9.7% |
2019 | A$0.74 B | 33.14% |
2018 | A$0.55 B | 86.26% |
2017 | A$0.30 B | 42.19% |
2016 | A$0.21 B | 698.47% |
2015 | A$26.46 M | -140.01% |
2014 | -A$66.16 Million | 338.24% |
2013 | -A$15.1 Million | -125.59% |
2012 | A$58.99 M | -215.13% |
2011 | -A$51.25 Million | -1087.77% |
2010 | A$5.18 M | -77.19% |
2009 | A$22.74 M |